SUSMED,Inc.

4263・Growth Market・Information & Communication

Official website

SUSMED,Inc.

4263・Growth Market・Information & Communication

Official website

SUSMED,Inc.4263

Reference Indicators

Market Cap

94¥100M

P/E (Forecast)

—

P/B

2.4x

Dividend Yield (Forecast)

0.00%

ROE

-9.2%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Net Sales	316	530	342	462	497
SG&A Expenses	309	394	452	476	562
Operating Income	-229	-48	-364	-299	-330
Non-operating Income	54	4	8	11	5
Non-operating Expenses	43	0	0	7	0
Ordinary Income	-217	-44	-357	-294	-325
Extraordinary Income	—	0	3	2	14
Extraordinary Losses	15	5	2	4	67
Pre-tax Income	-233	-49	-356	-297	-378
Income Taxes	0	1	1	1	3
Net Income	-233	-50	-357	-298	-382
EBITDA	-227	-42	-358	-291	-319
Operating Margin	-72.3%	-9.1%	-106.5%	-64.7%	-66.4%
ROA	-4.7%	-1.0%	-7.2%	-6.6%	-9.1%
ROE	-4.8%	-1.0%	-7.8%	-6.9%	-9.2%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
DTxプロダクト事業	300	118	39.3%
DTxプラットフォーム事業	162	33	20.4%